NCT05624541

Brief Summary

Cerebral palsy and other neuromotor disorders are more common in babies born preterm (\<37 weeks of gestation), due to various biological and environmental risk factors and the risk increases as the gestational age decreases. Earlier and more frequent screening with the use of developmental skills tests facilitates referral to early intervention programs. Current guidelines recommend using some combination of neuroimaging and neurological examination and assessments such as neonatal imaging, general movements (GMs), and Hammersmith Infant Neurological Examination (HINE) for early diagnosis and intervention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 22, 2022

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

December 27, 2022

Status Verified

October 1, 2022

Enrollment Period

11 months

First QC Date

November 14, 2022

Last Update Submit

December 22, 2022

Conditions

Keywords

infantvalidity and reliabilitypremature

Outcome Measures

Primary Outcomes (3)

  • Specific Test of Early Infant Motor Performance (STEP) Version 3.0

    The STEP test is a 10-item neurodevelopmental assessment that does not require special training, evaluating infants from term to corrected 3 months for rapid and early detection of motor problems. It evaluates the infant not only by the presence or absence of motor skills, but by the quality of movement. A term cut-off score of 16 or less and a three-month cut-off score of 22 or less are important criteria in developmental delay.

    Change from term age of infants (40 weeks) to 3 month

  • Hammersmith Infant Neurological examination (HINE)

    It is a neurodevelopmental assessment test accessible to all clinicians used for infants 2 to 24 months old. It is a 26-item test with a maximum score of 78 scored between 0-3. It has 3 sections: (1) neurological examination (26 items, scored) evaluating cranial nerve function, posture, movements, tone, reflexes, and reactions, (2) motor milestones (8 items, unscored), and (3) behaviour (3 items, unscored). Higher score indicates good neurological function.

    Change from the baseline of the HINE score at corrected age 3, 6th month of infants

  • Bayley Scales of Infant and Toddler Development (BSID -III)

    It is applied to evaluate the development in cognitive, language and movement areas in children whose corrected age is between 0-42 months. Movement scale consists of two parts as fine motor and gross motor. A score below 70 is a criterion for developmental delay.

    Change from the baseline of the BAYLEY-III score at corrected age 6th month of infants

Study Arms (1)

preterm Infant

30 premature infants with a gestational age of 37 weeks and below and a history of stay in the neonatal intensive care unit will be evaluated.

Diagnostic Test: Measurements

Interventions

MeasurementsDIAGNOSTIC_TEST

All infants at high risk of cp will be assessed by Specific Test of Early Infant Motor Performance (STEP) Version 3.0 at term age and at corrected age 3 months, by Hammersmith Infant Neurological Examination (HINE) a corrected age 3 and 6 months, also BAYLEY-III Infant and Toddler Development Assessment Scale (BAYLEY-III) at corrected 6 months.

Also known as: Measurements of neurological development.
preterm Infant

Eligibility Criteria

Age1 Month - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

A total of 30 infants will be included in the study. Based on the data of the previous study, the number of participants to be included in the study was found to be correlated with G\*Power 3.1.9.2 (Correlation: Bivariate) as p H1=0.89. The minimum number of individuals to be included in the sample of this study was calculated by taking effect size=0.60, α=0.05 and power=0.95, and it was found to be 30 in total. Since the effect size obtained from the sample study is large, it was preferred to use the correlation p H1=0.6 size in order to reach a larger sample size.

You may qualify if:

  • Babies born before \<37 weeks of gestation and treated in the neonatal intensive care unit
  • Infants with neurologic abnormalities (muscle hypertonia, hypotonia, hyperarousal, and abnormal general movements or cranial ultrasound abnormalities) at moderate to high risk of cerebral palsy
  • Infants referred to physiotherapy due to motor developmental delay and neurological dysfunction
  • Babies whose age range is between 0-12 months (corrected age will be calculated for premature babies)
  • Being diagnosed as a neurologically and developmentally risky baby
  • Babies who have completed medical treatments and are not in neonatal intensive care
  • Infants of families of infants who agreed to participate in the study and approved the informed consent form

You may not qualify if:

  • Babies with congenital cyanotic heart problems or cystic fibrosis
  • Babies with genetic disease or congenital anomalies
  • Infants on ventilator
  • Babies of families who do not accept to work

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University Pendik Training and Research Hospital

Istanbul, 34899, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyInfant, Premature, DiseasesPremature Birth

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Evrim Karadag-Saygi, Prof

    Marmara University

    STUDY DIRECTOR

Central Study Contacts

Kübra Kurt, MSc

CONTACT

Ayça Evkaya Acar, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2022

First Posted

November 22, 2022

Study Start

January 18, 2022

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

December 27, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations